Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
In previous studies concerning the sympathetic outflow during converting enzyme inhibition, no significant changes after chronic treatment could be observed. Therefore, we investigated the effects of the long-acting converting enzyme inhibitor ramipril on the neuronal and extraneuronal uptake of SHR. Ramipril was administered either i.v. or orally to SHR, whereas desipramine or corticosterone were additionally infused to block the neuronal or extraneuronal uptake of catecholamines. As an index of sympathetic outflow, plasma noradrenaline and adrenaline concentrations were determined during preganglionic stimulation of the spinal cord using HPLC and ELCD. Blood pressure of SHR was measured in a carotid artery and was significantly decreased in the ramipril treated group under resting and stimulating conditions. Ramipril did not influence stimulated sympathetic outflow. However, in acute and chronic experiments ramipril led to an additive effect to desipramine concerning stimulated circulating catecholamines. Similar results could be obtained after blocking the uptake-2 with corticosterone. 3H-NA-uptake into the hearts of SHR was significantly diminished by about 10% after chronic ramipril administration. It is suggested that ramipril is able to decrease the neuronal and extraneuronal uptake of catecholamines by an unspecific effect due to the comparably high lipophilicity. The blood pressure lowering effect of ramipril is not supported by an inhibition of presynaptic noradrenaline release.
Key wordsConverting enzyme inhibition spontaneously hypertensive rats (SHR) sympathetic outflow neuronal and extraneuronal uptake
Unable to display preview. Download preview PDF.
- 4.Erikson BM, Persson BA (1982) Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 228: 143–154Google Scholar
- 9.Maxwell RA, Keenan DP, Chaplin E, Roth B, Eckhardt SB (1969) Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol Exp Ther 66: 320–329Google Scholar
- 11.Schömig E, Michael-Hepp J, Bönisch H (1988) Inhibition of neuronal adrenaline uptake (uptakes) and desepramine binding by N-ethylmaleimide ( NEM ). Naunyn-Schmiedeberg’s Arch Pharmacol 337: 633–636Google Scholar
- 13.Trendelenburg U (1980) A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines. Rev Physiol Biochem Pharmacol 87:33 ffGoogle Scholar
- 15.Wenting GJ, Manin’t Veld AJ, Woitliez AJ, Derk FHM, Schalekamp MADH (1984) Captopril in treatment of severe acute and chronic heart failure. Progress in Pharmacology, 5/3: 107–112, Fischer Verlag, StuttgartGoogle Scholar